Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 46.44M | 44.11M | 42.12M | 41.44M | 40.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.44M | 44.11M | 42.12M | 41.44M | 40.49M |
| Cost of Revenue | 6.21M | 6.16M | 6.16M | 6.24M | 6.29M |
| Gross Profit | 40.23M | 37.95M | 35.96M | 35.20M | 34.20M |
| SG&A Expenses | 41.31M | 39.45M | 37.90M | 36.10M | 34.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -782.20K | -894.60K | -1.02M | -1.11M | -1.20M |
| Total Operating Expenses | 52.46M | 50.35M | 48.63M | 47.03M | 45.15M |
| Operating Income | -6.02M | -6.24M | -6.51M | -5.59M | -4.67M |
| Income Before Tax | -4.36M | -5.34M | -6.36M | -5.71M | -5.05M |
| Income Tax Expenses | 273.10K | 196.90K | 122.80K | 76.40K | 31.40K |
| Earnings from Continuing Operations | -4.63 | -5.53 | -6.49 | -5.79 | -5.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.63M | -5.53M | -6.49M | -5.79M | -5.08M |
| EBIT | -6.02M | -6.24M | -6.51M | -5.59M | -4.67M |
| EBITDA | -3.96M | -4.19M | -4.45M | -3.56M | -2.68M |
| EPS Basic | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.38B | 1.38B | 1.38B | 1.37B | 1.37B |
| Average Diluted Shares Outstanding | 1.38B | 1.38B | 1.38B | 1.37B | 1.37B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
